![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: KIF20B |
Gene summary for KIF20B |
![]() |
Gene information | Species | Human | Gene symbol | KIF20B | Gene ID | 9585 |
Gene name | kinesin family member 20B | |
Gene Alias | CT90 | |
Cytomap | 10q23.31 | |
Gene Type | protein-coding | GO ID | GO:0000278 | UniProtAcc | Q96Q89 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
9585 | KIF20B | LZE2T | Human | Esophagus | ESCC | 4.17e-04 | 9.77e-01 | 0.082 |
9585 | KIF20B | LZE4T | Human | Esophagus | ESCC | 2.08e-02 | 2.19e-01 | 0.0811 |
9585 | KIF20B | LZE22T | Human | Esophagus | ESCC | 4.65e-03 | 3.92e-01 | 0.068 |
9585 | KIF20B | LZE24T | Human | Esophagus | ESCC | 3.73e-03 | 2.23e-01 | 0.0596 |
9585 | KIF20B | P2T-E | Human | Esophagus | ESCC | 1.02e-24 | 7.92e-01 | 0.1177 |
9585 | KIF20B | P4T-E | Human | Esophagus | ESCC | 1.57e-11 | 5.96e-01 | 0.1323 |
9585 | KIF20B | P5T-E | Human | Esophagus | ESCC | 5.68e-14 | 4.72e-01 | 0.1327 |
9585 | KIF20B | P8T-E | Human | Esophagus | ESCC | 5.95e-08 | 2.92e-01 | 0.0889 |
9585 | KIF20B | P10T-E | Human | Esophagus | ESCC | 1.37e-07 | 2.65e-01 | 0.116 |
9585 | KIF20B | P12T-E | Human | Esophagus | ESCC | 2.45e-09 | 2.48e-01 | 0.1122 |
9585 | KIF20B | P15T-E | Human | Esophagus | ESCC | 1.27e-02 | 2.18e-01 | 0.1149 |
9585 | KIF20B | P16T-E | Human | Esophagus | ESCC | 6.89e-09 | 3.06e-01 | 0.1153 |
9585 | KIF20B | P19T-E | Human | Esophagus | ESCC | 4.25e-02 | 2.91e-01 | 0.1662 |
9585 | KIF20B | P20T-E | Human | Esophagus | ESCC | 2.65e-05 | 3.40e-01 | 0.1124 |
9585 | KIF20B | P21T-E | Human | Esophagus | ESCC | 5.45e-14 | 4.89e-01 | 0.1617 |
9585 | KIF20B | P22T-E | Human | Esophagus | ESCC | 1.81e-02 | 1.30e-01 | 0.1236 |
9585 | KIF20B | P23T-E | Human | Esophagus | ESCC | 4.61e-03 | 2.26e-01 | 0.108 |
9585 | KIF20B | P24T-E | Human | Esophagus | ESCC | 4.40e-04 | 2.65e-01 | 0.1287 |
9585 | KIF20B | P26T-E | Human | Esophagus | ESCC | 2.17e-11 | 4.18e-01 | 0.1276 |
9585 | KIF20B | P27T-E | Human | Esophagus | ESCC | 4.31e-07 | 2.95e-01 | 0.1055 |
Page: 1 2 3 4 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:014001414 | Esophagus | ESCC | mitotic nuclear division | 218/8552 | 287/18723 | 6.17e-26 | 1.78e-23 | 218 |
GO:003238618 | Esophagus | ESCC | regulation of intracellular transport | 243/8552 | 337/18723 | 3.20e-23 | 7.25e-21 | 243 |
GO:0033157110 | Esophagus | ESCC | regulation of intracellular protein transport | 169/8552 | 229/18723 | 3.31e-18 | 3.23e-16 | 169 |
GO:0032388110 | Esophagus | ESCC | positive regulation of intracellular transport | 152/8552 | 202/18723 | 7.89e-18 | 7.36e-16 | 152 |
GO:000734615 | Esophagus | ESCC | regulation of mitotic cell cycle | 293/8552 | 457/18723 | 8.00e-16 | 5.64e-14 | 293 |
GO:1904951111 | Esophagus | ESCC | positive regulation of establishment of protein localization | 216/8552 | 319/18723 | 1.01e-15 | 6.86e-14 | 216 |
GO:009031617 | Esophagus | ESCC | positive regulation of intracellular protein transport | 122/8552 | 160/18723 | 2.45e-15 | 1.49e-13 | 122 |
GO:0051222111 | Esophagus | ESCC | positive regulation of protein transport | 204/8552 | 303/18723 | 1.56e-14 | 8.38e-13 | 204 |
GO:00482853 | Esophagus | ESCC | organelle fission | 301/8552 | 488/18723 | 4.64e-13 | 2.12e-11 | 301 |
GO:00002802 | Esophagus | ESCC | nuclear division | 270/8552 | 439/18723 | 1.17e-11 | 4.24e-10 | 270 |
GO:000028115 | Esophagus | ESCC | mitotic cytokinesis | 58/8552 | 71/18723 | 4.34e-10 | 1.15e-08 | 58 |
GO:004578710 | Esophagus | ESCC | positive regulation of cell cycle | 196/8552 | 313/18723 | 9.27e-10 | 2.24e-08 | 196 |
GO:000716320 | Esophagus | ESCC | establishment or maintenance of cell polarity | 143/8552 | 218/18723 | 2.05e-09 | 4.65e-08 | 143 |
GO:003250614 | Esophagus | ESCC | cytokinetic process | 35/8552 | 39/18723 | 9.38e-09 | 1.90e-07 | 35 |
GO:000184115 | Esophagus | ESCC | neural tube formation | 75/8552 | 102/18723 | 9.68e-09 | 1.95e-07 | 75 |
GO:000184314 | Esophagus | ESCC | neural tube closure | 66/8552 | 88/18723 | 1.98e-08 | 3.82e-07 | 66 |
GO:000091016 | Esophagus | ESCC | cytokinesis | 115/8552 | 173/18723 | 2.48e-08 | 4.68e-07 | 115 |
GO:001402014 | Esophagus | ESCC | primary neural tube formation | 69/8552 | 94/18723 | 4.22e-08 | 7.76e-07 | 69 |
GO:006060614 | Esophagus | ESCC | tube closure | 66/8552 | 89/18723 | 4.24e-08 | 7.76e-07 | 66 |
GO:00070883 | Esophagus | ESCC | regulation of mitotic nuclear division | 78/8552 | 110/18723 | 6.96e-08 | 1.21e-06 | 78 |
Page: 1 2 3 4 5 6 7 8 9 10 11 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
KIF20B | SNV | Missense_Mutation | novel | c.4271A>G | p.Asn1424Ser | p.N1424S | Q96Q89 | protein_coding | tolerated(0.22) | benign(0.031) | TCGA-T3-A92N-01 | Oral cavity | head & neck squamous cell carcinoma | Male | >=65 | I/II | Unknown | Unknown | PD |
KIF20B | insertion | Nonsense_Mutation | novel | c.3282_3283insTAACTGTG | p.Tyr1095Ter | p.Y1095* | Q96Q89 | protein_coding | TCGA-C9-A47Z-01 | Oral cavity | head & neck squamous cell carcinoma | Female | >=65 | III/IV | Unknown | Unknown | SD | ||
KIF20B | insertion | Frame_Shift_Ins | novel | c.3202_3203insAGCAAATCTATGTT | p.Val1068GlufsTer6 | p.V1068Efs*6 | Q96Q89 | protein_coding | TCGA-H7-8502-01 | Oral cavity | head & neck squamous cell carcinoma | Male | <65 | I/II | Chemotherapy | unknown | SD | ||
KIF20B | SNV | Missense_Mutation | rs199753491 | c.644N>A | p.Ser215Asn | p.S215N | Q96Q89 | protein_coding | tolerated(0.45) | benign(0.198) | TCGA-EJ-5530-01 | Prostate | prostate adenocarcinoma | Male | <65 | 7 | Unknown | Unknown | SD |
KIF20B | SNV | Missense_Mutation | novel | c.1199C>T | p.Thr400Ile | p.T400I | Q96Q89 | protein_coding | deleterious(0) | possibly_damaging(0.908) | TCGA-B7-A5TJ-01 | Stomach | stomach adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD |
KIF20B | SNV | Missense_Mutation | c.5194N>C | p.Lys1732Gln | p.K1732Q | Q96Q89 | protein_coding | deleterious(0) | probably_damaging(0.991) | TCGA-BR-8680-01 | Stomach | stomach adenocarcinoma | Male | <65 | III/IV | Chemotherapy | oxaliplatin | CR | |
KIF20B | SNV | Missense_Mutation | c.3999N>T | p.Glu1333Asp | p.E1333D | Q96Q89 | protein_coding | tolerated(0.15) | benign(0.057) | TCGA-CD-A4MJ-01 | Stomach | stomach adenocarcinoma | Male | <65 | I/II | Chemotherapy | cisplatin | CR | |
KIF20B | SNV | Missense_Mutation | c.1979N>T | p.Cys660Phe | p.C660F | Q96Q89 | protein_coding | tolerated(0.11) | benign(0.216) | TCGA-D7-A4YU-01 | Stomach | stomach adenocarcinoma | Male | >=65 | III/IV | Chemotherapy | capecitabine | SD | |
KIF20B | SNV | Missense_Mutation | novel | c.1348A>G | p.Ile450Val | p.I450V | Q96Q89 | protein_coding | tolerated(0.88) | benign(0.212) | TCGA-VQ-A925-01 | Stomach | stomach adenocarcinoma | Male | >=65 | III/IV | Unknown | Unknown | PD |
KIF20B | SNV | Missense_Mutation | novel | c.8N>G | p.Ser3Cys | p.S3C | Q96Q89 | protein_coding | deleterious(0.04) | probably_damaging(0.943) | TCGA-VQ-AA64-01 | Stomach | stomach adenocarcinoma | Male | >=65 | III/IV | Chemotherapy | fluorouracil | PD |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |